
Progress in PBC: Seladelpar in Trial as Second-Line Therapy
Gastroenterology Learning Network
00:00
Addressing Symptoms in PBC with Seladelpar
This chapter discusses the importance of addressing symptoms in patients with PBC and how the drug Seladelpar may help improve symptoms such as itching, fatigue, abdominal discomfort, and poor sleep. It also highlights ongoing research on the association between Seladelpar efficacy and the cytokine IL-31.
Transcript
Play full episode